A carregar...
A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder
BACKGROUND: Even when patients experience remission with antidepressants, many continue to report anger attacks and excessive irritability despite continued treatment. Iloperidone antagonizes 5-HT-2a, D2, and alpha-1 receptors, which can have anti-aggressive effects. We examined iloperidone’s safety...
Na minha lista:
| Publicado no: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749740/ https://ncbi.nlm.nih.gov/pubmed/26913173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315618621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|